Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Mesh.i » - entrée « Hemagglutination Inhibition Tests »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hemagglutination < Hemagglutination Inhibition Tests < Hemagglutination Tests  Facettes :

List of bibliographic references indexed by Hemagglutination Inhibition Tests

Number of relevant bibliographic references: 53.
[0-50] [0 - 20][0 - 50][50-52][50-70]
Ident.Authors (with country if any)Title
000420 (2016) Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses.
000439 (2016) Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.
000498 (2015) A V Lyapunov ; S I Kolesnikov ; M A Khasnatinov ; E L Manzarova ; I V Petrova ; V V Dolgikh ; G A Danchinova[Child and Adolescent Interepydemic Immunity to Influenza Viruses].
000522 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
000565 (2015) Ankita Malik [Inde] ; V Vamsee Aditya Mallajosyula [Inde] ; Nripendra Nath Mishra [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
000691 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000A27 (2012) Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo IcardiPhase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
000C34 (2011) Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine]Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
000D60 (2011) Nobuko Ohshima [Japon] ; Yoshitaka Iba [Japon] ; Ritsuko Kubota-Koketsu [Japon] ; Yoshizo Asano [Japon] ; Yoshinobu Okuno [Japon] ; Yoshikazu Kurosawa [Japon]Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5
000D63 (2011) Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
000E85 (2010) Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio LedesmaEvaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.
000F91 (2010) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets
001062 (2009) Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie]Pandemic Vaccine Preparedness—Have We Left Something Behind?
001132 (2009) Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta SubbaraoA live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
001225 (2008) Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton KatlinskySafety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
001252 (2008) Joo Sub Lee [Corée du Sud] ; Hyun Soo Kim ; Sang Heui SeoGenetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine.
001259 (2008) H. Li [République populaire de Chine] ; Y. Zhang ; Z H Ning ; X M Deng ; Z X Lian ; N. LiEffect of selection for phagocytosis in dwarf chickens on immune and reproductive characters.
001391 (2007) Jae Min Song [Corée du Sud] ; Ki Duk Park ; Kwang Hee Lee ; Young Ho Byun ; Ju Hee Park ; Sung Han Kim ; Jae Hong Kim ; Baik Lin SeongBiological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
001479 (2006) Annette Schrauder ; Brunhilde Schweiger ; Udo Buchholz ; Walter Haas ; Daniel Sagebiel ; Adrienne Guignard ; Wiebke HellenbrandLaboratory exposure to influenza A H2N2, Germany, 2004-2005.
001660 (2004) N. Hehme [Allemagne] ; H. Engelmann ; W. Kuenzel ; E. Neumeier ; R. SaengerImmunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
001994 (1999) Jon D. Reuter [États-Unis] ; Andrzej Myc [États-Unis] ; Michael M. Hayes [États-Unis] ; Zhonghong Gan [États-Unis] ; Rene Roy [États-Unis] ; Dujie Qin [États-Unis] ; Rui Yin [États-Unis] ; Lars T. Piehler [États-Unis] ; Roseita Esfand [États-Unis] ; Donald A. Tomalia [États-Unis] ; James R. Baker [États-Unis]Inhibition of Viral Adhesion and Infection by Sialic-Acid-Conjugated Dendritic Polymers
001A96 (1998) A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
001B24 (1997) O. Andersen [Danemark] ; K. Vilsgaard Ravn ; I. Juul S Rensen ; G. Jonson ; E. Holm Nielsen ; S E SvehagSerum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.
001E15 (1994) M. A. Ball [États-Unis] ; T. Utsunomiya [États-Unis] ; K. Ikemoto [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis]The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice
001F93 (1991) P W Gill ; A M Murphy ; A L CunninghamInfluenza A(H1N1): a widening spectrum?
002064 (1990) H. Závadová [République tchèque] ; E. Domorázková ; J. Skovránková ; M. Vodicková ; P. Ragac ; V. Vonka[Reactivity and immunologic activity of polyvalent split influenza vaccine in children].
002137 (1989) M L Clements [États-Unis] ; S D Sears ; K. Christina ; B R Murphy ; M H SnyderComparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors.
002231 (1988) M. H. Pritchard [Royaume-Uni] ; N. Matthews [Royaume-Uni] ; Julia Munro [Royaume-Uni]ANTIBODIES TO INFLUENZA A IN A CLUSTER OF CHILDREN WITH JUVENILE CHRONIC ARTHRITIS
002420 (1985) D. B. Golubev [Russie] ; G. I. Karpukhin [Russie] ; S. S. Galitarov [Russie] ; G. M. Denisov [Russie]Type A influenza (H2N2) viruses isolated in Leningrad in 1980
002482 (1984) G I Karpukhin ; T L Popova ; L S Karpova ; L M Tsybalova ; G M Denisov[Antigenic anachronism of the influenza A(H2N2) viruses in Leningrad in 1980. I. The epidemiological and serological characteristics of the influenzal infection caused by A/Leningrad/80 (H2N2) viruses].
002483 (1984) D B Golubev ; S S Galitarov ; Iu M. Poliakov ; O M Litvinova ; A I Bannikov[Antigenic anachronism of influenza viruses A(H2N2) in Leningrad in 1980. II. The laboratory characteristics of influenza A/Leningrad/80 viruses].
002487 (1984) A. N. Slepushkin ; V. V. Ritova ; L. V. Feklisova ; G. I. Fedorova ; N. P. Obrosova-Serova ; E. S. Safonova ; L. M. Kupryashina ; E. V. Molibog ; V. A. Slepushkin ; V. M. ZhdanovResults of a two-year study of humoral immunity to influenza A and B viruses in children under the age of 14 years in Moscow and its suburbs*
002498 (1984) N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
002641 (1982) B L Lu ; R G Webster ; V S HinshawFailure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions.
002784 (1980) G Q Liu ; X C Gong ; J M Zhu ; G F Ren ; R L Fan ; W Q RuanAntigenic relationship between H1 and H2 of influenza A virus.
002871 (1979) M L Profeta ; D. De Vito ; M. Fasan[Serologic survey of human type A influenza virus infection following 10-year periods of prevalence of H3N2 strains].
002885 (1979) D L Murray ; D T Imagawa ; D M Okada ; J W St GemeAntibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.
002971 (1978) W. J. J. Anker ; A. K. Bakker ; N. MasurelCross-Protection in Mice After Immunization with H2N2, H3N2, and Heq2Neq2 Influenza Virus Strains
002B01 (1976) J M GwaltneyThe use of live attenuated influenza vaccine ts-1(E) in man.
002B03 (1976) V M Stealey ; D. Mccahon ; D S FreestonePreparation and characterization of live recombinant influenza vaccine.
002B49 (1976) J. Drescher [Allemagne] ; U. Desselberger [Allemagne]Kinetics of reactions of antihemagglutinin and antineuraminidase antibodies with H2N2 and H3N2 influenza virus strains and description of a modification of the photometric ACU method for titration of antineuraminidase antibodies
002B65 (1975) B. Tumová ; H J Eisengarten ; I. Siebelist-Konstantinow ; A. Stumpa ; R G WebsterA duck influenza virus with haemagglutinin related to that of A/Singapore/57 (H2N2) virus.
002C03 (1974) G. C. Schild ; J. S. Oxford ; W. R. Dowdle ; M. Coleman ; M. S. Pereira ; P. ChakravertyAntigenic variation in current influenza A viruses: evidence for a high frequency of antigenic `drift' for the Hong Kong virus
002C31 (1973) Alan P. Kendal ; Michael P. Kiley ; H. F. MaassabComparative Studies of Wild-Type and “Cold-Mutant” (Temperature-Sensitive) Influenza Viruses: Polypeptide Synthesis by an Asian (H2N2) Strain and Its Cold-Adapted Variant
002D76 (????) F G Nagieva ; N I Krasnova ; V G Nikulina ; O G Andzhaparidze[The protective effect of hemagglutinin-specific monoclonal antibodies in experimental influenza infection].
002D84 (????) E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
002D89 (????) N A Ivanova ; E B Grinbaum ; L Iu Taros ; T Ia Luzianina ; A A Smorodintsev[Serological foundation for the persisting circulation of influenza viruses A(HON1) and A(H2N2) among children].
002D91 (????) I V Kiseleva ; N V Larionova ; L C P. Teley ; L G Rudenko[Restriction analysis of genome composition of live influenza vaccine].
002D94 (????) D K L'Vov ; R Ia Podcherniaeva ; R. Webster ; M V Ronina ; T V Pysina[Production of recombinants antigenically identical to influenza virus strains circulating in nature].
002E16 (????) T V Ignat'Eva ; G N Trushinskaia ; E I Isaeva[Identification of influenza virus type A by solid-phase radioimmunological analysis].
002E37 (????) E I Isaeva ; Z I Rovnova[Characteristics of the antigenic composition of influenza A (H3N2) virus hemagglutinins isolated 1979-1080].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Hemagglutination Inhibition Tests" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Hemagglutination Inhibition Tests" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Hemagglutination Inhibition Tests
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021